Determination of C-reactive protein with an ultra-sensitivity immunochemiluminometric assay

Journal of Immunological Methods

Volumn 311, Issue 1-2, 2006, Pages 87-95

  Shiesh, Shu Chu ^a   Chou, Tse Chuan ^a   Lin, Xi Zhang ^a   Kao, Pai Chi ^b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b MAYO CLINIC   (United States)

Author keywords

Chinese; Immunometric assay; Ultra sensitivity C reactive protein

Indexed keywords

C REACTIVE PROTEIN; LATEX; MONOCLONAL ANTIBODY; POLYSTYRENE;

ADULT; AGED; ARTICLE; ASSAY; CALIBRATION; CHEMOLUMINESCENCE; CHINESE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; IMMUNOASSAY; IMMUNOCHEMISTRY; MALE; NEPHELOMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; REGRESSION ANALYSIS; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; TAIWAN; UNITED STATES; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; FEMALE; HUMANS; IMMUNOASSAY; LUMINESCENT MEASUREMENTS; MALE; MIDDLE AGED; REFERENCE VALUES; SEX FACTORS; TAIWAN;

EID: 33646085353     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2006.01.020     Document Type: Article

References (44)

1. Anand S.S., Yusuf S., Vuksan V., Devanesen S., Teo K.K., Montague P.A., et al. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet 356 (2000) 279-284
2. Bassuk S.S., Rifai N., and Ridker P.M. High-sensitivity C-reactive protein: clinical importance. Curr. Probl. Cardiol. 29 (2004) 439-493
3. Biasucci L.M., CDC, and AHA. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: application to clinical and public health practice: clinical use of inflammatory markers in patients with cardiovascular diseases: a background paper. Circulation 110 (2004) e560-e567
4. Chew D.P., Bhatt D.L., Robbins M.A., Penn M.S., Schneider J.P., Lauer M.S., et al. Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation 104 (2001) 992-997
5. Danesh J., Whincup P., Walker M., Lennon L., Thomson A., Appleby P., et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 321 (2000) 199-204
6. Devaraj S., and Jialal I. Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients. Free Radic. Biol. Med. 29 (2000) 790-792
7. Esposito K., Marfella R., Ciotola M., Di Palo C., Giugliano F., Giugliano G., et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 292 (2004) 1440-1446
8. Ford E.S., Giles W.H., Mokdad A.H., and Myers G.L. Distribution and correlates of C-reactive protein concentrations among adult US women. Clin. Chem. 50 (2004) 574-581
9. Hutchinson W.L., Koenig W., Frohlich M., Sund M., Lowe G.D., and Pepys M.B. Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population. Clin. Chem. 46 (2000) 934-938
10. Imhof A., Frohlich M., Loewel H., Helbecque N., Woodward M., Amouyel P., et al. Distributions of C-reactive protein measured by high-sensitivity assays in apparently healthy men and women from different populations in Europe. Clin. Chem. 49 (2003) 669-672
11. Kao P.C., Taylor R.L., and Heser D.W. C-peptide immunochemiluminometric assay developed from two seemingly identical polyclonal antisera. Ann. Clin. Lab. Sci. 22 (1992) 307-316
12. Kimberly M.M., Vesper H.W., Caudill S.P., Cooper G.R., Rifai N., Dati F., et al. Standardization of immunoassays for measurement of high-sensitivity C-reactive protein. Phase I: evaluation of secondary reference materials. Clin. Chem. 49 (2003) 611-616
13. Koenig W., Sund M., Frohlich M., Fischer H.G., Lowel H., Doring A., et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99 (1999) 237-242
14. Kuller L.H., Tracy R.P., Shaten J., and Meilahn E.N. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study: Multiple Risk Factor Intervention Trial. Am. J. Epidemiol. 144 (1996) 537-547
15. Lear S.A., Chen M.M., Birmingham C.L., and Frohlich J.J. The relationship between simple anthropometric indices and C-reactive protein: ethnic and gender differences. Metabolism 52 (2003) 1542-1546
16. Ledue T.B., and Rifai N. Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment. Clin. Chem. 49 (2003) 1258-1271
17. Ledue T.B., Weiner D.L., Sipe J.D., Poulin S.E., Collins M.F., and Rifai N. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ann. Clin. Biochem. 35 (1998) 745-753
18. Lee J., Heng D., Chia K.S., Chew S.K., Tan B.Y., and Hughes K. Risk factors and incident coronary heart disease in Chinese, Malay and Asian Indian males: the Singapore Cardiovascular Cohort Study. Int. J. Epidemiol. 30 (2001) 983-988
19. Libby P. Molecular bases of the acute coronary syndromes. Circulation 91 (1995) 2844-2850
20. MacGregor A.J., Gallimore J.R., Spector T.D., and Pepys M.B. Genetic effects on baseline values of C-reactive protein and serum amyloid A protein: a comparison of monozygotic and dizygotic twins. Clin. Chem. 50 (2004) 130-134
21. Macy E.M., Hayes T.E., and Tracy R.P. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin. Chem. 43 (1997) 52-58
22. Madsen T., Skou H.A., Hansen V.E., Fog L., Christensen J.H., Toft E., et al. C-reactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease. Am. J. Cardiol. 88 (2001) 1139-1142
23. Ockene I.S., Matthews C.E., Rifai N., Ridker P.M., Reed G., and Stanek E. Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin. Chem. 47 (2001) 444-450
24. Pepys M.B., and Hirschfield G.M. C-reactive protein: a critical update. J. Clin. Invest. 111 (2003) 1805-1812 (Erratum in: J Clin Invest. 2003;112:299)
25. Reed A.H., Henry R.J., and Mason W.B. Influence of statistical method used on the resulting estimate of normal range. Clin. Chem. 17 (1971) 275-284
26. Ridker P.M. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107 (2003) 363-369
27. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 336 (1997) 973-979 (Erratum in: N Engl J Med. 1997;337:356)
28. Ridker P.M., Buring J.E., Shih J., Matias M., and Hennekens C.H. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98 (1998) 731-733
29. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342 (2000) 836-843
30. Ridker P.M., Cannon C.P., Morrow D., Rifai N., Rose L.M., McCabe C.H., et al. Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators. C-reactive protein levels and outcomes after statin therapy. N. Engl. J. Med. 352 (2005) 20-28
31. Rifai N., and Ridker P.M. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin. Chem. 47 (2001) 403-411
32. Rifai N., and Ridker P.M. Population distributions of C-reactive protein in apparently healthy men and women in the United States: implication for clinical interpretation. Clin. Chem. 49 (2003) 666-669
33. Rifai N., Tracy R.P., and Ridker P.M. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin. Chem. 45 (1999) 2136-2141
34. Roberts W.L., Sedrick R., Moulton L., Spencer A., and Rifai N. Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Clin. Chem. 46 (2000) 461-468
35. Spector T.D., Hart D.J., Nandra D., Doyle D.V., Mackillop N., Gallimore J.R., et al. Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum. 40 (1997) 723-727
36. Tracy R.P., Lemaitre R.N., Psaty B.M., Ives D.G., Evans R.W., Cushman M., et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 1121-1127
37. Verma S., Wang C.H., Li S.H., Dumont A.S., Fedak P.W., Badiwala M.V., et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 106 (2002) 913-919
38. Verma S., Szmitko P.E., and Yeh E.T. C-reactive protein: structure affects function. Circulation 109 (2004) 1914-1917
39. Wasunna A., Whitelaw A., Gallimore R., Hawkins P.N., and Pepys M.B. C-reactive protein and bacterial infection in preterm infants. Eur. J. Pediatr. 149 (1990) 424-427
40. Whicher J.T., Ritchie R.F., Johnson A.M., Baudner S., Bienvenu J., Blirup-Jensen S., et al. New international reference preparation for proteins in human serum (RPPHS). Clin. Chem. 40 (1994) 934-938
41. Wilkins J., Gallimore J.R., Moore E.G., and Pepys M.B. Rapid automated high sensitivity enzyme immunoassay of C-reactive protein. Clin. Chem. 44 (1998) 1358-1361
42. Yamada S., Gotoh T., Nakashima Y., Kayaba K., Ishikawa S., Nago N., et al. Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population: Jichi Medical School Cohort Study. Am. J. Epidemiol. 153 (2001) 1183-1190
43. Yeh E.T., and Willerson J.T. Coming of age of C-reactive protein: using inflammation markers in cardiology. Circulation 107 (2003) 370-371
44. Zee R.Y., and Ridker P.M. Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis 162 (2002) 217-219